Illumina Inc (ILMN)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $31.30B
Last updated: Nov 17, 2026 at 11:06 AM ET
Illumina Inc (ILMN) P/E Ratio & Valuation History
Illumina (ILMN) trades at 37.7x trailing earnings and 6.6x sales. Its P/E of 37.7x is below its 5-year median of 58.1x. Its forward P/E is 33.6x. The median P/E across 11 similar companies is 26.8x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 12.2% higher over the next year. Its free cash flow yield is 3.5%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 37.7x |
| Forward P/E | 33.6x |
| Price to sales | 6.6x |
| Price to book | 9.5x |
| EV/EBITDA | 21.8x |
| Price to FCF | 28.3x |
| EV/FCF | 28.8x |
| PEG | 2.5 |
| FCF yield | 3.5% |
Historical Medians
Against its 10-year medians, its P/E is 33.5% below 56.7x, its P/S is 35.9% below 10.3x and its P/B is in line.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 37.7x | 58.1x | 56.7x |
| P/S | 6.6x | 5.2x | 10.3x |
| P/B | 9.5x | 5.3x | 9.5x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 27.0x in 2025 to 160.0x in 2023. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $131.16 | 27.0x | 4.7x | 7.4x |
| 2024 | $133.63 | 54.5x | 4.9x | 9.0x |
| 2023 | $139.24 | 160.0x | 4.9x | 3.9x |
| 2022 | $202.20 | 95.4x | 6.9x | 4.8x |
| 2021 | $380.44 | 63.8x | 12.6x | 5.6x |
| 2020 | $370.00 | 82.2x | 16.8x | 11.6x |
| 2019 | $331.74 | 50.4x | 13.8x | 10.6x |
| 2018 | $299.93 | 52.4x | 13.3x | 11.6x |
| 2017 | $218.49 | 54.5x | 11.6x | 11.4x |
| 2016 | $128.04 | 37.8x | 7.9x | 8.3x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ILMN
What is ILMN's forward P/E ratio?
Illumina has a forward P/E ratio of 33.6x.
Is ILMN stock overvalued?
GNG's valuation label for ILMN is Fairly valued. Its P/E of 37.7x compares with a median of 26.8x across 11 similar companies.
What is ILMN's price to sales ratio?
Illumina has a price to sales ratio of 6.6x.
What is Illumina's average P/E ratio over 5 years?
Illumina's median P/E over the last 5 years is 58.1x, from 60 month-end values through Oct 2026.
What is ILMN's PEG ratio?
Illumina has a PEG ratio of 2.5.
ILMN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts